Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation

Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation

US Patent 10946029 · Granted Mar 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dry powder inhaler and inhalation actuated mechanism thereof2021
Dry powder inhaler and inhalation actuated mechanism thereof2019
Dry powder formulation comprising a corticosteroid and a beta-adrenergic for adm2018
Dry powder formulation comprising a corticosteroid and a beta-adrenergic for adm2018
Dry powder formulation comprising a corticosteroid and a beta-adrenergic for adm2018
Dry powder formulation comprising a corticosteroid and a beta-adrenergic for adm2018
Particle size reduction of an antimuscarinic compound2018
Dry powder formulation comprising an anticholinergic, a corticosteroid and a bet2017
Process for preparing carrier particles for dry powders for inhalation2016
Dry powder formulation comprising an anticholinergic, a corticosteroid and a bet2016
Particle size reduction of an antimuscarinic compound2016
Dry powder formulation comprising a phosphodiesterase inhibitor2016